Tag Archives: Metformin

Possible Case: Januvia Efectos Secundarios – Januvia Cáncer, Januvia Pancreatitis, Januvia Demand

Home Page Español Januvia

Januvia es un medicamento recetado para tratar a adultos con diabetes tipo 2. En 25 de septiembre de 2009, la FDA emitió una revisión a la etiqueta de advertencia de la droga Januvia o Janumet–un medicamento de combinación compuesto por Januvia y metformina–con respecto a

Read More 0 Comments

UPDATE 1-Ambac says has final deal with bankrupt Detroit over bonds

Fri Jul 25, 2014 11:11am EDT

(Adds details and background of settlement)
July 25 (Reuters) – Ambac Assurance Corp said on
Friday its final settlement in Detroit’s bankruptcy case over
the treatment of limited-tax general obligation bonds that it
insured for the city would result in a 34 percent

Litigator of the Week: Michael Carvin of Jones Day

Two contradictory appellate court rulings this week framed the next battle over Obamacare. Carvin was at the center of both of them.


Already Registered? Sign In now
5 free articles* every 30 days, from other ALM publications
Exclusive discounts on ALM events and products
Litigation Daily digital newsletter,

Time for the Bank of England to show a steady hand

By Helene Durand

Fri Jul 25, 2014 11:58am EDT

LONDON, July 25 (IFR) – The Bank of England’s latest
curveball on the leverage ratio muddles the waters further in
what is already a fiendishly complicated UK bank capital
Just when UK banks thought it was safe to make

Settlement: Ameriprise Agrees Preliminary Settlement in Securities America Investor Class Action

April 13 2011New York, NY: A preliminary settlement has been reached by Ameriprise Financial and its brokerage unit, Securities America Inc, and clients who allege in they lost roughly $400 million on fraudulent private placements. The preliminary agreement would see Securities America pay $80 million, further to a separate

Possible Lawsuit: Temporary Cognitive Impairment Prompts FDA Labeling Change for Lunesta

May 16 2014Washington, DC: A new warning that the insomnia drug Lunesta (eszopiclone) can cause next-day impairment of driving and other activities that require alertness has been issued by The US Food and Drug Administration (FDA). A study of Lunesta found that the previously recommended dose of 3 mg